PH20061A - Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines - Google Patents
Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolinesInfo
- Publication number
- PH20061A PH20061A PH27964A PH27964A PH20061A PH 20061 A PH20061 A PH 20061A PH 27964 A PH27964 A PH 27964A PH 27964 A PH27964 A PH 27964A PH 20061 A PH20061 A PH 20061A
- Authority
- PH
- Philippines
- Prior art keywords
- diaminoquinazolines
- alkoxy
- substituted
- novel chloro
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9031379A | 1979-11-01 | 1979-11-01 | |
US06/126,838 US4287341A (en) | 1979-11-01 | 1980-03-03 | Alkoxy-substituted-6-chloro-quinazoline-2,4-diones |
Publications (1)
Publication Number | Publication Date |
---|---|
PH20061A true PH20061A (en) | 1986-09-18 |
Family
ID=26782146
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH24784A PH17552A (en) | 1979-11-01 | 1980-10-29 | Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines,their pharmaceutical compositions and method of use |
PH27963A PH18321A (en) | 1979-11-01 | 1982-10-08 | Novel chloro and alkoxy substituted 2-4 diamino-quinazolines |
PH27964A PH20061A (en) | 1979-11-01 | 1982-10-08 | Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH24784A PH17552A (en) | 1979-11-01 | 1980-10-29 | Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines,their pharmaceutical compositions and method of use |
PH27963A PH18321A (en) | 1979-11-01 | 1982-10-08 | Novel chloro and alkoxy substituted 2-4 diamino-quinazolines |
Country Status (15)
Country | Link |
---|---|
US (1) | US4287341A (en) |
EP (1) | EP0028473B1 (en) |
AR (1) | AR227650A1 (en) |
AU (1) | AU520344B2 (en) |
CA (1) | CA1146546A (en) |
DE (1) | DE3069944D1 (en) |
DK (1) | DK153399C (en) |
ES (5) | ES496442A0 (en) |
FI (1) | FI77455C (en) |
GR (1) | GR70728B (en) |
IE (1) | IE50366B1 (en) |
IL (1) | IL61375A (en) |
PH (3) | PH17552A (en) |
PT (1) | PT72007B (en) |
YU (1) | YU41745B (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4607034A (en) * | 1979-10-29 | 1986-08-19 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinazoline derivatives and pharmaceutical composition thereof |
GB2068961B (en) | 1980-02-13 | 1983-11-30 | Sankyo Co | Quinazoline derivatives |
US4351832A (en) * | 1980-04-18 | 1982-09-28 | American Home Products Corporation | 2-(Piperazinyl)-4-pyrimidinamines |
FI70411C (en) | 1980-12-29 | 1986-09-19 | Pfizer | FORM OF ANTHYPERTENSIVE 4-AMINO-6,7-DIMETOXY-2-PIPERAZINOQUINAZOLE DERIVATIVES |
ES515338A0 (en) * | 1981-09-09 | 1983-11-01 | Orion Yhtymae Oy | "METHOD FOR THE PREPARATION OF SUBSTITUTED PIPERIDINYLQUINAZOLIDINES". |
US4656174A (en) * | 1982-07-24 | 1987-04-07 | Pfizer Inc. | Quinoline therapeutic agents |
CH651027A5 (en) * | 1982-11-12 | 1985-08-30 | Sandoz Ag | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE. |
CS236097B1 (en) * | 1983-06-01 | 1985-05-15 | Jan Koenig | Acylderivatives of 2-piperazinochinazoline and method of their preparation |
US4933460A (en) * | 1983-08-22 | 1990-06-12 | Hoechst-Roussel Pharmaceuticals Inc. | Piperdine substituted phenyl hydrazones |
US4634769A (en) * | 1984-09-25 | 1987-01-06 | Ortho Pharmaceutical Corporation | Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts |
FR2582513B1 (en) * | 1985-05-28 | 1988-08-05 | Synthelabo | PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE |
AT384218B (en) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | METHOD FOR PRODUCING NEW CHINAZOLINE DERIVATIVES |
US4668787A (en) * | 1985-12-20 | 1987-05-26 | Ortho Pharmaceutical Corporation | 5,6-dialkoxy-4-imino-2(1H)quinazolinone derivatives |
US4672116A (en) * | 1985-12-20 | 1987-06-09 | Ortho Pharmaceutical Corporation | Substituted 5,6-dialkoxyquinazoline derivatives |
IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
EP0360936A1 (en) * | 1988-09-29 | 1990-04-04 | Siemens Aktiengesellschaft Österreich | Method for the conversion of a sampled analog input signal |
EP0367888A1 (en) * | 1988-11-08 | 1990-05-16 | ISTITUTO LUSO FARMACO D'ITALIA S.p.A. | 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity |
GB8910722D0 (en) * | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
CA2015981A1 (en) * | 1989-05-10 | 1990-11-10 | Thomas H. Brown | Compounds |
JPH05507290A (en) * | 1990-11-06 | 1993-10-21 | フアイザー・インコーポレイテツド | Quinazoline derivatives for enhanced antitumor activity |
PT100905A (en) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | BICYCLE HYGIENEOUS HETEROCYCLIC COMPOUNDS CONTAINING BENZENE, CYCLOHEXAN OR PYRIDINE AND PYRIMIDINE, PYRIDINE OR IMIDAZOLE SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
IL108630A0 (en) * | 1993-02-18 | 1994-05-30 | Fmc Corp | Insecticidal substituted 2,4-diaminoquinazolines |
DE4429978A1 (en) * | 1994-08-24 | 1996-02-29 | Bayer Ag | Process for the preparation of quinazoline-2,4-diones |
US5747490A (en) * | 1995-09-29 | 1998-05-05 | Merck & Co., Inc. | Alpha 1b adrenergic receptor antagonists |
WO1997020823A2 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
CA2173408C (en) * | 1996-04-03 | 2001-09-04 | K.S. Keshava Murthy | Process for the manufacture of intermediates suitable to make doxazosin,terazosin, prazosin, tiodazosin and related antihypertensive medicines |
IT1286302B1 (en) * | 1996-04-10 | 1998-07-08 | Rotta Research Lab | CHINAZOLINE-4-AMINO-2- (PIPERIDINO-1-IL-4-SUBSTITUTED) WITH ANTI-HYPERTENSIVE ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND USE |
GB9708917D0 (en) * | 1997-05-01 | 1997-06-25 | Pfizer Ltd | Compounds useful in therapy |
DZ3415A1 (en) * | 2000-08-31 | 2002-03-07 | Chiron Corp | GUANIDINOBENZAMIDES AS MC4-R AGONISTS. |
US6716840B2 (en) * | 2001-04-09 | 2004-04-06 | Chiron Corporation | Guanidino compounds |
JP2005524649A (en) * | 2002-02-25 | 2005-08-18 | カイロン コーポレーション | Intranasal administration of MC4-R agonist |
DE60333937D1 (en) | 2002-05-23 | 2010-10-07 | Novartis Vaccines & Diagnostic | SUBSTITUTED QUINAZOLINONE COMPOUNDS |
EP1539754A4 (en) | 2002-08-23 | 2009-02-25 | Novartis Vaccines & Diagnostic | Benzimidazole quinolinones and uses thereof |
BRPI0314830B8 (en) | 2002-09-30 | 2021-05-25 | Bayer Ip Gmbh | fused azole-pyrimidine derivatives |
US6608200B1 (en) * | 2002-10-07 | 2003-08-19 | Council Of Scientific & Industrial Research | Process for the preparation of N-(2,3-Dihydrobenzo[1,4]dioxin-2-carbonyl)piperazine |
KR20060018217A (en) * | 2003-05-23 | 2006-02-28 | 카이론 코포레이션 | Guanidino-substituted quinazolinone compounds as mc4-r agonists |
CA2544492C (en) | 2003-11-07 | 2013-01-29 | Chiron Corporation | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
KR20060105785A (en) * | 2003-11-19 | 2006-10-11 | 카이론 코포레이션 | Quinazolinone compounds with reduced bioaccumulation |
US7923573B2 (en) * | 2004-10-27 | 2011-04-12 | Daiichi Sankyo Company, Limited | Benzene compound having 2 or more substituents |
WO2012027495A1 (en) | 2010-08-27 | 2012-03-01 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
US20140080810A1 (en) | 2010-11-15 | 2014-03-20 | Exelixis, Inc. | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture |
GB202006382D0 (en) | 2020-04-30 | 2020-06-17 | Spermatech As | Use |
CN113105350B (en) * | 2021-04-06 | 2023-11-24 | 利尔化学股份有限公司 | Process for preparing 2-amino-3-alkyl-5-chlorobenzoic acid |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1117130B (en) * | 1959-10-14 | 1961-11-16 | Basf Ag | Process for the preparation of 2,4-dihydroxyquinazolines |
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US3669968A (en) * | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
DE2027645A1 (en) * | 1970-06-05 | 1971-12-09 | Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz | Piperazinylalkyl quinazolone (4) den vate, process for their preparation and medicinal products containing them |
GB1334633A (en) * | 1972-04-07 | 1973-10-24 | Parke Davis & Co | Quinazoline compounds and methods for their production |
JPS536156B2 (en) * | 1972-10-30 | 1978-03-04 | ||
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4001237A (en) * | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | Oxazole, isoxazole, thiazole and isothiazole amides |
US4001238A (en) * | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | 1,3,4-oxadiazole amides |
US4060615A (en) * | 1976-02-18 | 1977-11-29 | Mead Johnson & Company | 2-Piperazinyl-6,7-dimethoxyquinazolines |
US4101548A (en) * | 1977-02-22 | 1978-07-18 | Bristol-Myers Company | 1,2,3-Thiadiazole amides |
US4098788A (en) * | 1977-06-20 | 1978-07-04 | Bristol-Myers Company | Process for preparing quinazolines |
US4102885A (en) * | 1977-06-20 | 1978-07-25 | Bristol-Myers Company | Process for preparing 2,4-dihaloquinazolines |
-
1980
- 1980-03-03 US US06/126,838 patent/US4287341A/en not_active Expired - Lifetime
- 1980-10-16 EP EP80303658A patent/EP0028473B1/en not_active Expired
- 1980-10-16 DE DE8080303658T patent/DE3069944D1/en not_active Expired
- 1980-10-29 PH PH24784A patent/PH17552A/en unknown
- 1980-10-29 AR AR283044A patent/AR227650A1/en active
- 1980-10-30 FI FI803397A patent/FI77455C/en not_active IP Right Cessation
- 1980-10-30 IL IL61375A patent/IL61375A/en unknown
- 1980-10-30 GR GR63246A patent/GR70728B/el unknown
- 1980-10-30 CA CA000363579A patent/CA1146546A/en not_active Expired
- 1980-10-30 YU YU2775/80A patent/YU41745B/en unknown
- 1980-10-31 IE IE2258/80A patent/IE50366B1/en unknown
- 1980-10-31 ES ES80496442A patent/ES496442A0/en active Granted
- 1980-10-31 PT PT72007A patent/PT72007B/en unknown
- 1980-10-31 DK DK462380A patent/DK153399C/en not_active IP Right Cessation
- 1980-10-31 AU AU63896/80A patent/AU520344B2/en not_active Ceased
-
1981
- 1981-11-11 ES ES507043A patent/ES507043A0/en active Granted
- 1981-11-11 ES ES507041A patent/ES507041A0/en active Granted
- 1981-11-11 ES ES507042A patent/ES8206491A1/en not_active Expired
-
1982
- 1982-10-06 ES ES516286A patent/ES516286A0/en active Granted
- 1982-10-08 PH PH27963A patent/PH18321A/en unknown
- 1982-10-08 PH PH27964A patent/PH20061A/en unknown
Also Published As
Publication number | Publication date |
---|---|
YU277580A (en) | 1983-06-30 |
CA1146546A (en) | 1983-05-17 |
ES507042A0 (en) | 1982-08-16 |
PH17552A (en) | 1984-09-20 |
AU520344B2 (en) | 1982-01-28 |
PT72007B (en) | 1981-08-31 |
YU41745B (en) | 1987-12-31 |
IL61375A (en) | 1986-09-30 |
DE3069944D1 (en) | 1985-02-21 |
ES8207520A1 (en) | 1982-10-01 |
PH18321A (en) | 1985-05-29 |
AR227650A1 (en) | 1982-11-30 |
IE50366B1 (en) | 1986-04-02 |
FI77455B (en) | 1988-11-30 |
PT72007A (en) | 1980-11-01 |
GR70728B (en) | 1983-01-24 |
ES8400415A1 (en) | 1983-10-16 |
ES507043A0 (en) | 1982-10-01 |
ES8303360A1 (en) | 1983-02-01 |
EP0028473A1 (en) | 1981-05-13 |
IE802258L (en) | 1981-05-01 |
FI77455C (en) | 1989-03-10 |
DK153399C (en) | 1988-12-19 |
DK462380A (en) | 1981-05-02 |
IL61375A0 (en) | 1980-12-31 |
AU6389680A (en) | 1981-05-07 |
ES8202334A1 (en) | 1982-01-16 |
FI803397L (en) | 1981-05-02 |
ES496442A0 (en) | 1982-01-16 |
EP0028473B1 (en) | 1985-01-09 |
ES507041A0 (en) | 1983-02-01 |
DK153399B (en) | 1988-07-11 |
US4287341A (en) | 1981-09-01 |
ES516286A0 (en) | 1983-10-16 |
ES8206491A1 (en) | 1982-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH20061A (en) | Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines | |
GB2064520B (en) | A-aryl-1h-1,2,4-triazole-1-ethanols | |
IL60243A0 (en) | Novel 4-aroylimidazol-2-ones | |
IL59829A0 (en) | Substituted 9,10-anthracene-bishydrazones | |
ZA807296B (en) | Novel mercaptoorganosiloxanes | |
JPS5679692A (en) | Novel pyridothienotriazines | |
GB2044770B (en) | 24,24 - difluoro- 25 - hydroxycholecalciferol | |
NZ193666A (en) | 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles | |
NZ194046A (en) | Certain 6,7-disubstituted-3-methyl-1,2,3,5-tetrahydro-imidazo (2,1-b)quinazolin-2-ones | |
JPS565463A (en) | Novel 44aroylimidazolee22ones | |
JPS55130985A (en) | Novel betaatrialkoxysilylthiopropionamide | |
JPS5699462A (en) | Novel hydroxyphenylketone | |
GB2055667B (en) | Guillotines | |
IL75705A (en) | 1,2,5-thiadiazole-1-oxides | |
ZA804183B (en) | 1,2,4-thiadiazolyloxyphenylureas | |
GB2042549B (en) | 25 - hydroxy-cholecalciferol - 26,23 - lactone | |
CS744680A2 (en) | Mechanismus pro membranovou spojku, zejmena pro automobilni vozidla | |
GB2040932B (en) | 1 - substituted - 3,4 - epoxypyrrolidines | |
CS515881A2 (en) | Zpusob pripravy oktahydropyrazolo(3,4 g) chinolinu | |
CS361079A2 (en) | Hnaci jednotka, zvlaste pro visuty retezovy dopravnik | |
GB2118169B (en) | 1,1,1-trichlorotriacontane | |
ZA786692B (en) | 2-aminoethyl-1,4-benzodioxans | |
JPS5669678A (en) | Flighttsimulator break | |
ZW26280A1 (en) | Novel sulfinylamides | |
JPS56113777A (en) | Novel dibenzopyranes |